Literature DB >> 12021514

Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases.

Junichiro James Kazama1, Keiko Kutsuwada, Ken Ataka, Hiroki Maruyama, Fumitake Gejyo.   

Abstract

A clinical investigation was conducted to clarify the reliability and efficacy of serum cystatin C measurement for estimation of the glomerular filtration rate (GFR). Two hundred twelve patients with various renal diseases enrolled in the study. All patients were evaluated for 24-hour creatinine clearance (24 h C(Cr)) and the standard sodium thiosulfate clearance test (C(Thio)) within a week of blood sample collection. Serum cystatin C concentration was determined by a particle-enhanced immunonephelometry method. C(Thio) and 1/cystatin C, 24 h C(Cr), 1/beta2-microglobulin and 1/creatinine were well correlated. The correlation coefficients for C(Thio) obtained by 24 h C(Cr) and 1/cystatin C were comparable to each other (0.701 vs. 0.679). Receiver-operated characteristic (ROC) analysis revealed that 24 h C(Cr) showed the highest area under the curve when C(Thio) = 60 ml/min or C(Thio) = 100 ml/min were applied as the discrimination point. However, the ROC value obtained by cystatin C was slightly greater than 24 h C(Cr) when C(Thio) = 80 ml/min was used as the discrimination point. Patient age, gender, glucose tolerance, presence of proteinuria, systemic inflammation, lupus, or systemic use of steroids did not interfere in the relationship between C(Thio) and 1/cystatin C. In conclusion, serum cystatin C measurement is an excellent diagnostic test for detecting patients with subclinical renal dysfunction. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021514     DOI: 10.1159/000057599

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  26 in total

1.  Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus.

Authors:  R Lertnawapan; A Bian; Y H Rho; P Raggi; A Oeser; J F Solus; T Gebretsadik; A Shintani; C M Stein
Journal:  Lupus       Date:  2011-11-09       Impact factor: 2.911

Review 2.  Commentary: clinical diagnostic use of cystatin C.

Authors:  Davis Massey
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

3.  Effect of rhBNP on renal function in STEMI-HF patients with mild renal insufficiency undergoing primary PCI.

Authors:  Kun Xing; Xianghua Fu; Yanbo Wang; Wei Li; Xinshun Gu; Guozhen Hao; Qing Miao; Shiqiang Li; Yunfa Jiang; Weize Fan; Wei Geng
Journal:  Heart Vessels       Date:  2015-01-31       Impact factor: 2.037

4.  Assessment of serum cystatin C in children with congenital solitary kidney.

Authors:  Anna Wasilewska; Walentyna Zoch-Zwierz; Iwona Jadeszko; Tadeusz Porowski; Anna Biernacka; Alicja Niewiarowska; Agata Korzeniecka-Kozerska
Journal:  Pediatr Nephrol       Date:  2006-03-30       Impact factor: 3.714

5.  Optimal equation for estimation of glomerular filtration rate in autosomal dominant polycystic kidney disease: influence of tolvaptan.

Authors:  Tsuyoshi Yamaguchi; Eiji Higashihara; Takatsugu Okegawa; Isao Miyazaki; Kikuo Nutahara
Journal:  Clin Exp Nephrol       Date:  2018-05-22       Impact factor: 2.801

6.  Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study.

Authors:  Bruce A Perkins; Robert G Nelson; Betsy E P Ostrander; Kristina L Blouch; Andrzej S Krolewski; Bryan D Myers; James H Warram
Journal:  J Am Soc Nephrol       Date:  2005-03-23       Impact factor: 10.121

7.  Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study.

Authors:  Clara Y Jones; Camille A Jones; Ira B Wilson; Tamsin A Knox; Andrew S Levey; Donna Spiegelman; Sherwood L Gorbach; Frederick Van Lente; Lesley A Stevens
Journal:  Am J Kidney Dis       Date:  2008-05-02       Impact factor: 8.860

Review 8.  Biomarkers in heart failure: a clinical review.

Authors:  J Paul Rocchiccioli; John J V McMurray; Anna F Dominiczak
Journal:  Heart Fail Rev       Date:  2008-12-03       Impact factor: 4.214

9.  Para-capillary electron-dense deposits reduce glomerular filtration in patients with primary glomerular diseases.

Authors:  Sachiko Fukase; Junichiro J Kazama; Honami Mori; Seitaro Iguchi; Tetsuro Takeda; Mitsuhiro Ueno; Shinichi Nishi; Ichiei Narita; Fumitake Gejyo
Journal:  Clin Exp Nephrol       Date:  2006-03       Impact factor: 2.801

10.  Serum cystatin C measured by a sol particle homogeneous immunoassay can accurately detect early impairment of renal function.

Authors:  Hiroe Sato; Junichiro J Kazama; Takeshi Kuroda; Ichiei Narita; Masaaki Nakano; Fumitake Gejyo
Journal:  Clin Exp Nephrol       Date:  2008-04-17       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.